Pharmaceuticals, Biotechnology and Life Sciences
Aker’s revenue is reflecting lower than usual distributor stock depletion of PIFA Heparin/PF4 Rapid tests during the summer months. However, the company expects the demand to return to normal in 4Q.
Akers Biosciences has appointed Raza Bokhari M.D. as a Non-executive Director of the company.
Akers Biosciences, Inc. a medical device company focused on reducing the cost of healthcare through faster, easier diagnostics, has announced that all development specifications have been finalized and production has commenced for its two transformational breath tests designed for the health and wellness industry and consumers.